Impact of Statin Therapy on Plasma MMP-3, MMP-9, and TIMP-1 Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
- 10 January 2017
- journal article
- review article
- Published by SAGE Publications in Angiology
- Vol. 68 (10), 850-862
- https://doi.org/10.1177/0003319716688301
Abstract
Tissue inhibitors of metalloproteinases (TIMPs) and matrix metalloproteinases (MMPs) are associated with the development of atherosclerosis and cardiovascular disease. Statin therapy has been shown to modulate MMPs and TIMP-1 levels, but clinical findings have not been conclusive. This study aimed to systematically review the clinical findings on the impact of statin therapy on plasma MMP-9, MMP-3, and TIMP-1 levels and calculate an effect size for the mentioned effect through a meta-analysis of available data. A total of 10 eligible studies with 11 treatment arms were included in the meta-analysis. Statin therapy had no significant effect on plasma MMP-9 (standardized mean difference [SMD]: −0.23, 95% confidence interval [CI]: −0.69 to 0.24, P = .345) nor MMP-3 concentrations (SMD: −0.004, 95% CI: −0.60 to 0.59, P = .990). However, meta-analysis demonstrated that statin therapy significantly decreases plasma TIMP-1 levels (SMD: −0.30, 95% CI: −0.56 to −0.03, P = .029). Random-effects meta-regression indicated that neither treatment duration nor changes in low-density lipoprotein cholesterol levels are associated with changes in plasma MMP-9 levels following statin therapy. The results of the present meta-analysis suggested a significant reduction in plasma concentrations of TIMP-1, but not MMP-9 and MMP-3, following statin therapy.Keywords
This publication has 62 references indexed in Scilit:
- Simvastatin therapy decreases MMP-9 levels in obese womenThe Journal of Clinical Pharmacology, 2013
- Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean womenClinical Biochemistry, 2012
- Pleiotropic effects of pitavastatinBritish Journal of Clinical Pharmacology, 2012
- Plaque Rupture is a Determinant of Vascular Events in Carotid Artery Atherosclerotic Disease: Involvement of Matrix Metalloproteinases 2 and 9Journal of Clinical Neurology, 2011
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesionSeminars in Cancer Biology, 2010
- Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular DiseaseVascular and Endovascular Surgery, 2010
- Comparison Effect of Atorvastatin (10 versus 80 mg) on Biomarkers of Inflammation and Oxidative Stress in Subjects With Metabolic SyndromeThe American Journal of Cardiology, 2008
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein: The PIOSTAT StudyJournal of the American College of Cardiology, 2007
- Increased Matrix Metalloproteinase-9 Activity in Unstable Carotid PlaquesStroke, 2000